Clinical Trials Directory

Trials / Completed

CompletedNCT01324791

Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
General Public Hospital Zell am See · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Endoscopic full thickness gastroplication (Plicator-Procedure) has the potential to be a safe and effective alternative to laparoscopic antireflux surgery (LARS)to improve symptoms of GERD. This prospective randomized study compares objective and subjective outcome parameters of Plicator with that of LARS.

Conditions

Interventions

TypeNameDescription
PROCEDUREanti-reflux surgery

Timeline

First posted
2011-03-29
Last updated
2011-03-29

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01324791. Inclusion in this directory is not an endorsement.

Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GE (NCT01324791) · Clinical Trials Directory